Impact of Elexacaftor-Tezacaftor-Ivacaftor on lung disease in cystic fibrosis. Gushue C, Eisner M, Bai S, Johnson T, et al. Pediatr Pulmonol 2023;58:2308-2316.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gushue C, Eisner M, Bai S, Johnson T, et al. Impact of Elexacaftor-Tezacaftor-Ivacaftor on lung disease in cystic fibrosis. Pediatr Pulmonol 2023;58:2308-2316.
PMID: 37222417